Precision Therapeutics
Business Services · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(651) 389-4800Revenue
<$5 MillionStock Symbol
AIPTIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Precision Therapeutics
Precision Therapeutics Inc is a company that operates in the Research & Development industry. It employs 20to49 people and has 1Mto5M of revenue.Explore more
Precision Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Precision Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Precision Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Precision Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Precision Therapeutics
Funding: Get notified immidiatlly once Precision Therapeutics has new funding data
Click to see if Precision Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Precision Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Check out if Precision Therapeutics is spiking on competitors!
Check if Precision Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Precision Therapeutics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Precision Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Precision Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Precision Therapeutics.
Precision Therapeutics Tech Stack
A closer look at the technologies used by Precision Therapeutics
Precision Therapeutics News & Media
Predictive Oncology’s Wholly Owned Subsidiary Helomics announces the start of its drug repurposing project using its ground-breaking PeDAL™ platform for ovarian cancer
MINNEAPOLIS, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced today that it will start an in-house drug repurposing project, focused on ovarian cancer, using its proprietary AI-driven, patient centric discovery platform – PeDAL™. The project will use PeDAL to rapidly and cost-effectively profile panel of existing drugs against hundreds of patieLitchfield Hills Research Rates Predictive Oncology a Buy on Recent Analyst Report
MINNEAPOLIS, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced today that equity research firm, Litchfield Hills Research LLC, released its first analyst coverage report on (Nasdaq: POAI), rating the Company a "Buy" under its three-tiered (buy-hold-sell) rating system.Soluble Biotech, a Wholly Owned Subsidiary of Predictive Oncology, Inked Contract with Large Pharmaceutical Company
MINNEAPOLIS, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced today that its wholly owned subsidiary Soluble Biotech, Inc. just inked another contract with a large pharmaceutical company. The work will involve using Soluble Biotech’s proprietary protein formulation technology to improve the solubility and stability of a protein therapeutic destPredictive Oncology Reports That Its Wholly Owned Subsidiary, TumorGenesis, Has Sold Media to Two Top Research Medical Centers
EAGAN, Minn., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced today that its wholly owned subsidiary TumorGenesis, Inc. in the last quarter has sold media to two top research medical centers, one in New York City and the other in Boston, Massachusetts. Both the New York City and the Boston orders are repeat orders and are focused
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Precision Therapeutics
Sign Up For FreeTo access detailed company insights
Precision Therapeutics Inc is a company that operates in the Research & Development industry. It employs 20to49 people and has 1Mto5M of revenue.... Read More
